UniProt ID | EIF3B_MOUSE | |
---|---|---|
UniProt AC | Q8JZQ9 | |
Protein Name | Eukaryotic translation initiation factor 3 subunit B {ECO:0000255|HAMAP-Rule:MF_03001} | |
Gene Name | Eif3b | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 803 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression.. | |
Protein Sequence | MQDAENVAVPEAAEERAEPARQQPASESPPTDEAAGSGGSEVGQTEDAEEDAEAGPEPEVRAKPAAQSEEETATSPAASPTPQSAERSPSQEPSAPGKAEAVGEQARGHPSAGAEEEGGSDGSAAEAEPRALENGEADEPSFSDPEDFVDDVSEEELLGDVLKDRPQEADGIDSVIVVDNVPQVGPDRLEKLKNVIHKIFSKFGKIINDYYPEEDGKTKGYIFLEYASPAHAVDAVKNADGYKLDKQHTFRVNLFTDFDKYMTISDEWDIPEKQPFKDLGNLRYWLEEAECRDQYSVIFESGDRTSIFWNDVKDPVSIEERARWTETYVRWSPKGTYLATFHQRGIALWGGDKFKQIQRFSHQGVQLIDFSPCERYLVTFSPLMDTQDDPQAIIIWDILTGHKKRGFHCESSAHWPIFKWSHDGKFFARMTLDTLSIYETPSMGLLDKKSLKISGIKDFSWSPGGNIIAFWVPEDKDIPARVTLMQLPTRQEIRVRNLFNVVDCKLHWQKNGDYLCVKVDRTPKGTQGVVTNFEIFRMREKQVPVDVVEMKETIIAFAWEPNGSKFAVLHGEAPRISVSFYHVKSNGKIELIKMFDKQQANTIFWSPQGQFVVLAGLRSMNGALAFVDTSDCTVMNIAEHYMASDVEWDPTGRYVVTSVSWWSHKVDNAYWLWTFQGRLLQKNNKDRFCQLLWRPRPPTLLSQDQIKQIKKDLKKYSKIFEQKDRLSQSKASKELVERRRTMMEDFRQYRKMAQELYMKQKNERLELRGGVDTDELDSNVDDWEEETIEFFVTEEVIPLGSQE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MQDAENVA -------CCCHHHCC | 8.00 | - | |
26 | Phosphorylation | PARQQPASESPPTDE HHHCCCCCCCCCCCC | 45.34 | 25619855 | |
28 | Phosphorylation | RQQPASESPPTDEAA HCCCCCCCCCCCCCC | 33.41 | 27087446 | |
31 | Phosphorylation | PASESPPTDEAAGSG CCCCCCCCCCCCCCC | 50.27 | 24723360 | |
37 | Phosphorylation | PTDEAAGSGGSEVGQ CCCCCCCCCCCCCCC | 34.94 | 27087446 | |
40 | Phosphorylation | EAAGSGGSEVGQTED CCCCCCCCCCCCCCC | 32.41 | 27087446 | |
45 | Phosphorylation | GGSEVGQTEDAEEDA CCCCCCCCCCHHHHH | 29.88 | 27087446 | |
68 | Phosphorylation | RAKPAAQSEEETATS CCCCCCCCCCHHCCC | 42.10 | 24925903 | |
72 | Phosphorylation | AAQSEEETATSPAAS CCCCCCHHCCCCCCC | 38.22 | 24925903 | |
74 | Phosphorylation | QSEEETATSPAASPT CCCCHHCCCCCCCCC | 42.54 | 24925903 | |
75 | Phosphorylation | SEEETATSPAASPTP CCCHHCCCCCCCCCC | 15.30 | 24925903 | |
79 | Phosphorylation | TATSPAASPTPQSAE HCCCCCCCCCCCCCC | 31.26 | 27087446 | |
81 | Phosphorylation | TSPAASPTPQSAERS CCCCCCCCCCCCCCC | 31.31 | 27087446 | |
84 | Phosphorylation | AASPTPQSAERSPSQ CCCCCCCCCCCCCCC | 33.04 | 27087446 | |
88 | Phosphorylation | TPQSAERSPSQEPSA CCCCCCCCCCCCCCC | 22.02 | 25521595 | |
90 | Phosphorylation | QSAERSPSQEPSAPG CCCCCCCCCCCCCCC | 48.71 | 27087446 | |
94 | Phosphorylation | RSPSQEPSAPGKAEA CCCCCCCCCCCCHHH | 46.47 | 27742792 | |
98 | Ubiquitination | QEPSAPGKAEAVGEQ CCCCCCCCHHHHCHH | 41.83 | 27667366 | |
111 | Phosphorylation | EQARGHPSAGAEEEG HHCCCCCCCCCCCCC | 33.39 | 27087446 | |
120 | Phosphorylation | GAEEEGGSDGSAAEA CCCCCCCCCCCCCCC | 50.05 | 27087446 | |
123 | Phosphorylation | EEGGSDGSAAEAEPR CCCCCCCCCCCCCCC | 29.33 | 27087446 | |
141 | Phosphorylation | NGEADEPSFSDPEDF CCCCCCCCCCCHHHH | 35.02 | 22942356 | |
143 | Phosphorylation | EADEPSFSDPEDFVD CCCCCCCCCHHHHCC | 57.50 | 27087446 | |
153 | Phosphorylation | EDFVDDVSEEELLGD HHHCCCCCHHHHHHH | 46.41 | 22942356 | |
191 | Ubiquitination | VGPDRLEKLKNVIHK CCHHHHHHHHHHHHH | 70.16 | - | |
198 | Acetylation | KLKNVIHKIFSKFGK HHHHHHHHHHHHHHH | 34.03 | - | |
198 | Ubiquitination | KLKNVIHKIFSKFGK HHHHHHHHHHHHHHH | 34.03 | - | |
201 | Phosphorylation | NVIHKIFSKFGKIIN HHHHHHHHHHHHHHH | 30.46 | 30387612 | |
202 | Ubiquitination | VIHKIFSKFGKIIND HHHHHHHHHHHHHHH | 47.60 | 27667366 | |
205 | Acetylation | KIFSKFGKIINDYYP HHHHHHHHHHHHCCC | 43.47 | 22826441 | |
205 | Ubiquitination | KIFSKFGKIINDYYP HHHHHHHHHHHHCCC | 43.47 | - | |
217 | Acetylation | YYPEEDGKTKGYIFL CCCCCCCCEEEEEEE | 60.43 | 23954790 | |
226 | Phosphorylation | KGYIFLEYASPAHAV EEEEEEEECCHHHHH | 17.96 | 23984901 | |
228 | Phosphorylation | YIFLEYASPAHAVDA EEEEEECCHHHHHHH | 23.01 | 26745281 | |
237 | Ubiquitination | AHAVDAVKNADGYKL HHHHHHHHCCCCCCC | 48.41 | - | |
242 | Phosphorylation | AVKNADGYKLDKQHT HHHCCCCCCCCCCCE | 14.66 | 30387612 | |
246 | Ubiquitination | ADGYKLDKQHTFRVN CCCCCCCCCCEEEEE | 55.18 | 27667366 | |
246 | Malonylation | ADGYKLDKQHTFRVN CCCCCCCCCCEEEEE | 55.18 | 26320211 | |
265 | Phosphorylation | FDKYMTISDEWDIPE HHHCCCCCCCCCCCC | 21.95 | 25338131 | |
273 | Ubiquitination | DEWDIPEKQPFKDLG CCCCCCCCCCCCCCC | 58.90 | - | |
277 | Ubiquitination | IPEKQPFKDLGNLRY CCCCCCCCCCCCHHH | 59.74 | - | |
277 | Acetylation | IPEKQPFKDLGNLRY CCCCCCCCCCCCHHH | 59.74 | - | |
295 | Phosphorylation | EAECRDQYSVIFESG HHHCCCEEEEEEECC | 14.81 | 23567750 | |
296 | Phosphorylation | AECRDQYSVIFESGD HHCCCEEEEEEECCC | 11.78 | 23567750 | |
305 | Phosphorylation | IFESGDRTSIFWNDV EEECCCCCEEEECCC | 30.80 | 23567750 | |
313 | Ubiquitination | SIFWNDVKDPVSIEE EEEECCCCCCCCHHH | 60.21 | 27667366 | |
327 | Phosphorylation | ERARWTETYVRWSPK HHHHCEEEEEEECCC | 21.68 | 25367039 | |
328 | Phosphorylation | RARWTETYVRWSPKG HHHCEEEEEEECCCC | 5.04 | 25367039 | |
353 | Ubiquitination | IALWGGDKFKQIQRF EEEECCHHHHCHHHH | 58.71 | - | |
353 | Acetylation | IALWGGDKFKQIQRF EEEECCHHHHCHHHH | 58.71 | 22826441 | |
373 | Glutathionylation | QLIDFSPCERYLVTF EEEECCCCCEEEEEE | 4.50 | 24333276 | |
409 | Glutathionylation | HKKRGFHCESSAHWP CCCCCCCCCCCCCCC | 5.18 | 24333276 | |
436 | Phosphorylation | RMTLDTLSIYETPSM EEEECHHEEEECCCC | 25.80 | 25367039 | |
438 | Phosphorylation | TLDTLSIYETPSMGL EECHHEEEECCCCCC | 15.46 | 18563927 | |
440 | Phosphorylation | DTLSIYETPSMGLLD CHHEEEECCCCCCCC | 12.05 | 17203969 | |
448 | Ubiquitination | PSMGLLDKKSLKISG CCCCCCCCCCCEECC | 44.20 | - | |
483 | Phosphorylation | KDIPARVTLMQLPTR CCCCCEEEEEECCCC | 15.80 | 28059163 | |
489 | Phosphorylation | VTLMQLPTRQEIRVR EEEEECCCCHHEHHH | 54.28 | 18779572 | |
505 | Ubiquitination | LFNVVDCKLHWQKNG CCCEEECEEECEECC | 38.63 | - | |
514 | Phosphorylation | HWQKNGDYLCVKVDR ECEECCCEEEEEECC | 11.91 | - | |
524 | Ubiquitination | VKVDRTPKGTQGVVT EEECCCCCCCCCEEE | 74.17 | 27667366 | |
524 | Acetylation | VKVDRTPKGTQGVVT EEECCCCCCCCCEEE | 74.17 | 23806337 | |
541 | Ubiquitination | EIFRMREKQVPVDVV EEEEECCCCCCCEEE | 46.35 | 27667366 | |
541 | Acetylation | EIFRMREKQVPVDVV EEEEECCCCCCCEEE | 46.35 | 23806337 | |
593 | Acetylation | NGKIELIKMFDKQQA CCEEEEEEEECHHHC | 46.25 | 22826441 | |
633 | Phosphorylation | FVDTSDCTVMNIAEH EEECCCCCEEEHHHH | 27.99 | - | |
641 | Phosphorylation | VMNIAEHYMASDVEW EEEHHHHHHCCCCEE | 5.96 | - | |
702 | Phosphorylation | PRPPTLLSQDQIKQI CCCCCCCCHHHHHHH | 34.52 | 18779572 | |
716 | Phosphorylation | IKKDLKKYSKIFEQK HHHHHHHHHHHHHHH | 17.38 | 28059163 | |
718 | Ubiquitination | KDLKKYSKIFEQKDR HHHHHHHHHHHHHHH | 48.61 | - | |
718 | Malonylation | KDLKKYSKIFEQKDR HHHHHHHHHHHHHHH | 48.61 | 26320211 | |
723 | Malonylation | YSKIFEQKDRLSQSK HHHHHHHHHHHCHHH | 37.30 | 26320211 | |
727 | Phosphorylation | FEQKDRLSQSKASKE HHHHHHHCHHHHHHH | 33.05 | - | |
733 | Acetylation | LSQSKASKELVERRR HCHHHHHHHHHHHHH | 60.98 | 23806337 | |
733 | Ubiquitination | LSQSKASKELVERRR HCHHHHHHHHHHHHH | 60.98 | 27667366 | |
759 | Ubiquitination | MAQELYMKQKNERLE HHHHHHHHHHHHHCE | 44.56 | 27667366 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EIF3B_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EIF3B_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EIF3B_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of EIF3B_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-74; SER-75; SER-79;SER-120 AND SER-123, AND MASS SPECTROMETRY. | |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75 AND SER-79, AND MASSSPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120 AND SER-123, ANDMASS SPECTROMETRY. | |
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79; SER-120 AND SER-123,AND MASS SPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68; THR-74; SER-75;SER-79; SER-90; SER-120 AND SER-123, AND MASS SPECTROMETRY. | |
"A differential phosphoproteomic analysis of retinoic acid-treated P19cells."; Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D.; J. Proteome Res. 6:3174-3186(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120 AND SER-123, ANDMASS SPECTROMETRY. | |
"Comprehensive identification of phosphorylation sites in postsynapticdensity preparations."; Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R.,Burlingame A.L.; Mol. Cell. Proteomics 5:914-922(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120, AND MASSSPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-440, AND MASSSPECTROMETRY. | |
"Phosphoproteomic analysis of the developing mouse brain."; Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.; Mol. Cell. Proteomics 3:1093-1101(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-31, AND MASSSPECTROMETRY. |